Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-09
DOI
10.3389/fimmu.2019.02131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances on CD8+ Tregs and their potential in transplantation
- (2018) Séverine Bézie et al. TRANSPLANTATION
- Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice
- (2018) Séverine Bézie et al. Frontiers in Immunology
- Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
- (2018) Laurie S. Conklin et al. PHARMACOLOGICAL RESEARCH
- Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents
- (2017) Alan S. Robertson et al. NEUROMUSCULAR DISORDERS
- Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy
- (2016) David Gloss et al. NEUROLOGY
- Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice
- (2016) Margaret E. Benny Klimek et al. PLoS One
- Soluble Milk Protein Supplementation with Moderate Physical Activity Improves Locomotion Function in Aging Rats
- (2016) Aude Lafoux et al. PLoS One
- Antigen- and Cytokine-Driven Accumulation of Regulatory T Cells in Visceral Adipose Tissue of Lean Mice
- (2015) Dmitriy Kolodin et al. Cell Metabolism
- Effect of genetic background on the dystrophic phenotype inmdxmice
- (2015) William D. Coley et al. HUMAN MOLECULAR GENETICS
- Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficientmdxMice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway
- (2015) Cheng-Cao Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts
- (2015) Marie Bleakley et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy
- (2015) Jana Zschüntzsch et al. JOURNAL OF NEUROCHEMISTRY
- Fibrinogen-Like Protein 2/Fibroleukin Induces Long-Term Allograft Survival in a Rat Model through Regulatory B Cells
- (2015) Séverine Bézie et al. PLoS One
- Immune-mediated pathology in Duchenne muscular dystrophy
- (2015) Amy S. Rosenberg et al. Science Translational Medicine
- Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade
- (2015) Laura Pelosi et al. EBioMedicine
- Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
- (2014) Thibaut Larcher et al. PLoS One
- Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy
- (2014) S. A. Villalta et al. Science Translational Medicine
- A Special Population of Regulatory T Cells Potentiates Muscle Repair
- (2013) Dalia Burzyn et al. CELL
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- Anti-Dystrophin T Cell Responses in Duchenne Muscular Dystrophy: Prevalence and a Glucocorticoid Treatment Effect
- (2013) Kevin M. Flanigan et al. HUMAN GENE THERAPY
- Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases
- (2012) Séverine Ménoret et al. FASEB JOURNAL
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search